2018
DOI: 10.21037/acs.2018.03.13
|View full text |Cite
|
Sign up to set email alerts
|

Status of branched endovascular aortic arch repair

Abstract: Multiple medical device manufacturers are developing branched endografts for thoracic endovascular aortic repair (TEVAR), to provide a minimally invasive alternative for the treatment of aortic arch pathologies in patients who are deemed unfit for open or hybrid arch repair. Different branched endografts have been introduced, with varying number, size and orientation of the branches that redirect flow to the supra-aortic arteries. We present an overview of the currently investigated devices and review their ou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
48
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 61 publications
(49 citation statements)
references
References 33 publications
0
48
0
1
Order By: Relevance
“…Because of its superior early and mid-term outcomes over open surgery, the use of TEVAR is rapidly increasing [2]. The treatment range for TEVAR is extending with endografts deployed more proximally into the aortic arch and in younger patients [3][4][5]. Current endografts are made of materials much stiffer than the native thoracic aorta [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Because of its superior early and mid-term outcomes over open surgery, the use of TEVAR is rapidly increasing [2]. The treatment range for TEVAR is extending with endografts deployed more proximally into the aortic arch and in younger patients [3][4][5]. Current endografts are made of materials much stiffer than the native thoracic aorta [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…As occurred for pure ascending TEVAR, arch branched technology is constrained by anatomical landmarks, aortic sizing, and curvatures. While technical success was in the 84-100% range, mortality rate has been reported up to 20% and stroke rate up to 40% due to extensive manipulation in severely diseased aortas (10,(21)(22)(23). However, a significant reduction over time due to learning curve effects has been reported and the incidence of type 1a endoleak has also been reported as less than that after total debranching (10,24) ( Figure 6A,B).…”
Section: Branched Stent Graftmentioning
confidence: 97%
“…Endovascular repair of the ascending aorta and arch has been described in case reports, but there are ongoing trials investigating new devices specific for these anatomic zones. [34][35][36] The management of patients with acute type B aortic dissection (ATBAD) is based on complicated or uncomplicated patient presentations. Patients presenting with severe hypertension, persistent pain, malperfusion, or rupture are considered complicated.…”
Section: Aortic Dissectionmentioning
confidence: 99%